Cargando…
Iroquois homeobox 2 suppresses cellular motility and chemokine expression in breast cancer cells
BACKGROUND: Disseminated tumor cells (DTCs) can be detected using ultrasensitive immunocytochemical assays and their presence in the bone marrow can predict the subsequent occurrence of overt metastasis formation and metastatic relapse. Using expression profiling on early stage primary breast tumors...
Autores principales: | Werner, Stefan, Stamm, Hauke, Pandjaitan, Mutiha, Kemming, Dirk, Brors, Benedikt, Pantel, Klaus, Wikman, Harriet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642646/ https://www.ncbi.nlm.nih.gov/pubmed/26560478 http://dx.doi.org/10.1186/s12885-015-1907-4 |
Ejemplares similares
-
Iroquois Homeobox Protein 2 Identified as a Potential Biomarker for Parkinson’s Disease
por: Sim, Hyuna, et al.
Publicado: (2020) -
Loss of Iroquois homeobox transcription factors 3 and 5 in osteoblasts disrupts cranial mineralization
por: Cain, Corey J., et al.
Publicado: (2016) -
The Proangiogenic Effect of Iroquois Homeobox Transcription Factor Irx3 in Human Microvascular Endothelial Cells
por: Scarlett, Kisha, et al.
Publicado: (2015) -
Medicine among the Iroquois
por: Stone, Eric
Publicado: (1934) -
Iroquois Homeobox 1 Acts as a True Tumor Suppressor in Multiple Organs by Regulating Cell Cycle Progression()
por: Jung, In Hye, et al.
Publicado: (2019)